Virginiamycin S1
Virginiamycin S1 Basic information
- Product Name:
- Virginiamycin S1
- Synonyms:
-
- Virginiamycin S1
- Antibiotic 1754Z3B
- N-[(3-Hydroxy-2-pyridinyl)carbonyl]cyclo[L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4-oxo-L-pipecoloyl-L-phenyl Gly-]
- N-[(3-Hydroxy-2-pyridyl)carbonyl]cyclo(L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4-oxo-L-2-piperidinecarbonyl-L-phenyl Gly-)
- Staphylomycin S
- Cebin V, Eskalin V, EskaMicin, Stafac, StephyloMycin, MikaMycin, Ostreogrycin, Patricin, PristinaMycin, StreptograMin, VernaMycin.
- VirginiaMycin coMplex
- Antibiotic 899, Staphylomycin S
- CAS:
- 23152-29-6
- MF:
- C43H49N7O10
- MW:
- 823.89
- EINECS:
- 245-462-6
- Product Categories:
-
- antibiotic
- Mol File:
- 23152-29-6.mol
Virginiamycin S1 Chemical Properties
- Melting point:
- 240-242°
- alpha
- D20 -28° (c = 1 in ethanol)
- storage temp.
- ?20°C
- solubility
- methanol: soluble5mg/mL
- form
- powder
- color
- white
Virginiamycin S1 Usage And Synthesis
Uses
Virginiamycin complex is defined as a mixture of 75% ostreogrycin A (virginamycin M1) and 25% virginiamycin S1, together with the less abundant S analogues. As the two major components have quite different solubilities, these proportions are not readily achieved or used. BioAustralis has isolated and re-combined the individual components to provide the defined components of virginiamycin complex. The composition of the complex is important as Virginiamycin S1 acts a synergist, binding to the conformational change of the peptidyl transferase centre of the 50S ribosome induced by ostreogrycin A.
Uses
Virginiamycin S1 is one of a family of depsipeptide antibiotics co-produced with ostreogrycin A and used as a synergistic mixture. Virginiamycin S1 acts a synergist, binding to the conformational change of the peptidyl transferase centre of the 50S ribosome induced by ostreogrycin A.
Contact allergens
Like the other streptogramin, pristinamycin, virginiamycin is made of two subunits, virginiamycin S1 and virginiamycin M1. Dermatitis was quite common in people using the formerly available topical virginiamycin. Occupational dermatitis was observed in the pharmaceutical industry, in breeders, and in a surgeon who used topical virginiamycin on postoperative wounds (personal observation).
Virginiamycin S1 Supplier
- Tel
- info@bocsci.com
- Tel
- 0755-66853366-
- sales@chem-strong.com
- Tel
- 021-64609169-
- kewelchemexp@yahoo.com
- Tel
- 022-65378550- ;022-65378550-
- sales@altascientific.com;marketing@altascientific.com
- Tel
- 021-65675885
- info@efebio.com
Virginiamycin S1 (23152-29-6)Related Product Information
- PRISTINAMYCIN
- 4-[N-Methyl-4-(methylamino)-L-phenylalanine]virginiamycin S1
- Virginiamycin S1
- PYRIDINE-2-CARBOXYLIC ACID (2-AMINO-ETHYL)-AMIDE
- Pipecolamide
- ETHYL[(1-ETHYLPIPERIDIN-2-YL)METHYL]AMINE
- ETHYL[(1-METHYLPIPERIDIN-2-YL)METHYL]AMINE
- N-benzylpiperidine-2-carboxamide
- Methyl[(1-methylpiperidin-2-yl)methyl]amine
- C-(1-METHYL-PIPERIDIN-2-YL)-METHYLAMINE
- 1-butyrylpiperidin-4-one
- N-Acetyl-4-piperidone
- 1-Propyl-4-piperidone
- Quinupristin
- ETHYL[(1-PROPYLPIPERIDIN-2-YL)METHYL]AMINE
- N-(1-phenylethyl)piperidine-2-carboxamide
- CHEMBRDG-BB 9070682
- 1-ethylpiperidine-2-methylamine